[ad_1]
After 18 months of hyping up artificial intelligence and its potentially transformative impact on both corporate profits and human productivity, Wall Street appears to be turning more skeptical.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...